Inventabio

Based on a comprehensive WikiFX assessment, Inventabio does not demonstrate the hallmarks of a safe and reliable broker. The entity holds a very low WikiFX risk score of 1.42, which is a direct reflection of its significant operational deficiencies. The core issue is its complete lack of valid regulatory licenses from any recognized financial authority such as the FCA, ASIC, or Switzerland's own FINMA. This means client funds are not protected under standard safeguards like segregation from company assets or participation in investor compensation funds. For these reasons, engaging with Inventabio involves substantial risk.

No. According to WikiFX data, Inventabio is not a regulated broker. The detailed review confirms that the entity does not possess any valid trading licenses from major authoritative financial regulators, including the UK's Financial Conduct Authority (FCA), the Australian Securities and Investments Commission (ASIC), or the Swiss Financial Market Supervisory Authority (FINMA). Its registration in Switzerland does not equate to regulatory oversight for forex trading activities. Operating without regulation is a major risk factor for traders.

Inventabio does not explicitly list its minimum deposit requirements in its public-facing materials. This lack of clear, upfront information on a fundamental trading condition is atypical of transparent brokerage operations. Prospective clients are advised to approach with caution, as undisclosed terms often accompany entities with poor transparency records.

Specific information regarding trading platform support, including MetaTrader 4 (MT4) or MetaTrader 5 (MT5), is not detailed in the broker's publicly available materials. The absence of clear platform specifications, combined with its unregulated status, makes it difficult to assess the quality and stability of its trading environment.